MACROGEN Renews CI After 19 Years, Making A Great Leap Forward To Be A Global Leader Of Personalized Genomic Medicine

SEOUL, South Korea--(BUSINESS WIRE)--The personalized medicine and biotechnology company, Macrogen (headed by Hyonyong Chong; www.macrogen.com) (KOSDAQ:038290), has announced a new Corporate Identity (CI) for a great leap forward to become a global leader of personalized genomic medicine.

Help employers find you! Check out all the jobs and post your resume.